CYP 0.00% 28.0¢ cynata therapeutics limited

Ann: Strategic Review of Cynata Clinical Development Portfolio, page-3

  1. 15,398 Posts.
    lightbulb Created with Sketch. 5514
    Good to see progress on some trials but in relation to GVHD "expected to commence" sounds a little ominous .... perhaps CYP are in fact waiting for another biotech's response from the FDA given how many times the trial has been postponed ?




    upload_2023-7-24_10-9-11.png
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $50.29M
Open High Low Value Volume
27.5¢ 28.0¢ 27.5¢ $29.16K 104.4K

Buyers (Bids)

No. Vol. Price($)
3 25074 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 44128 1
View Market Depth
Last trade - 13.07pm 26/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.